Bonnie L. Bassler - 30 Mar 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: Director
Signature: /s/Bonnie L. Bassler
Issuer symbol: REGN
Transactions as of: 30 Mar 2022
Net transactions value: -$395,622
Form type: 4
Filing time: 01 Apr 2022, 16:08:09 UTC
Previous filing: 05 Jan 2022
Next filing: 01 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Options Exercise	$472,378	+1,240	+115%	$380.95	2,322	30 Mar 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$868,000	-1,240	-53%	$700.00	1,082	30 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	REGN	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-1,240	-17%	$0.000000	6,199	30 Mar 2022	Common Stock	1,240	$380.95	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2	The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.